arrow
Back
S

Steven M. Rowe

gregory fleming james cystic fibrosis research center

71H-index
433Paper Count
2.9WCitation Count
Published Papers 196
Publication Date
A ferret model demonstrates sustained fibrosis, restrictive physiology, and airway proximalization
err2025-11-27
err0
errOAAI
errJacelyn E. Peabody Lever; Qian Li; Nikoleta Pavelkova; Shah S. Hussain; Sayan Bakshi; Janna Q. Ren; Luke I. Jones; Kajal Jadhav; Jared P. Kennemur; Mason Weupe; Javier Campos-Gomez; Liping Tang; Jeremie M. Peabody Lever; Dezhi Wang; Denise D. Stanford; Jeremy B. Foote; Kevin S. Harrod; Harrison Kim; Scott E. Phillips; Steven M. Rowe
errShare
errSave
Identity, functional consequences, and context effects of amino acids inserted during suppression of CFTR nonsense mutations
err2025-09-27
err0
errOAAI
errKari Thrasher; Jianguo Chen; Lianwu Fu; Dominique Benson; Jenna Ekstrom; Audra A. Hargett; Matthew B. Renfrow; Steven M. Rowe; Kim M. Keeling; David M. Bedwell
errShare
errSave
Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor/tezacaftor/ivacaftor: Findings from the promise study
err2025-06-06
err0
errOAAI
errJennifer T Duong; Hillary S Hayden; Adrian J Verster; Christopher E Pope; Carson Miller; null Kelsi Penewit; Stephen J Salipante; Steven M Rowe; George M Solomon; David Nichols; Andrea Kelly; Sarah Jane Schwarzenberg; Steven D Freedman; Lucas R Hoffman
errShare
errSave
ACE-2 blockade and TMPRSS2 inhibition mitigate SARS-CoV-2 severity following cigarette smoke exposure in airway epithelial cells in vitro
err2025-06-02
err0
errOAAI
errShah S. Hussain; Emily Falk Libby; Jacelyn E. Peabody Lever; Jennifer L. Tipper; Scott E. Phillips; Marina Mazur; Qian Li; Javier Campos-Gómez; Kevin S. Harrod; Steven M. Rowe
errShare
errSave
Cholesterol and triglyceride concentrations following 12-18 months of clinically prescribed elexacaftor-tezacaftor-ivacaftor-PROMISE sub-study
err2025-06-01
err0
errOAAI
errRosara Bass; Michael Stalvey; George Solomon; Steven Rowe; David Nichols; Sarah Jane Schwarzenberg; Steven Freedman; Rachel Walega; Andrea Kelly
errShare
errSave
Toward in vivo bronchoscopic functional CFTR assessment using a short circuit current measurement probe
err2025-02-01
err0
PREAI
errOtuya, David O.; Liu, Zhongyu; Joseph, Reny; Hanafy, Mohammed A.; Vijaykumar, Kadambari; Stanford, Denise; Raju, S. Vamsee; Baker, Elizabeth H.; Rowe, Steven M.; Tearney, Guillermo J.; Solomon, George M.
errShare
errSave
Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO
err2024-12-09
err1
errOAAI
errChan, Christine L.; Bezerra, Meghan Shirley; Stefanovski, Darko; Gallop, Robert J.; Walega, Rachel; Donaldson, Scott H.; Frederick, Carla A.; Freedman, Steven D.; Gelfond, Daniel; Hoffman, Lucas R.; Narkewicz, Michael R.; Rowe, Steven M.; Sagel, Scott D.; Schwarzenberg, Sarah Jane; Solomon, George M.; Stalvey, Michael S.; Kelly, Andrea; PROMISE Endocrine Substudy Grp
errShare
errSave
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis
err2024-11-01
err1
PREAI
errMorgan, Sarah J.; Nichols, David P.; Ni, Windy; Hong, Gina; Salipante, Stephen J.; Solomon, George M.; Rowe, Steven M.; Clancy, John P.; Cramer, Robert A.; Singh, Pradeep K.
errShare
errSave
Elexacaftor/tezacaftor/ivacaftor's effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment
err2024-09-05
err1
errOAAI
errMorgan, Sarah J.; Coulter, Ellis; Betts, Hannah L.; Solomon, George M.; Clancy, John P.; Rowe, Steven M.; Nichols, David P.; Singh, Pradeep K.
errShare
errSave
Metachrony drives effective mucociliary transport via a calcium-dependent mechanism
err2024-09-01
err1
PREAI
errLever, Jacelyn E. Peabody; Turner, K. Brett; Fernandez, Courtney M.; Leung, Hui Min; Hussain, Shah Saddad; Shei, Ren-Jay; Lin, Vivian Y.; Birket, Susan E.; Chu, Kengyeh K.; Tearney, Guillermo J.; Rowe, Steven M.; Solomon, George M.
errShare
errSave
Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)
err2024-09-01
err0
PREAI
errBaker, Elizabeth; Harris, William T.; Guimbellot, Jennifer S.; Bliton, Kyle; Rowe, Steven M.; Raju, S. Vamsee; Oates, Gabriela R.
errShare
errSave
Reduced sialylation of airway mucin impairs mucus transport by altering the biophysical properties of mucin
err2024-07-17
err1
errOAAI
errHarris, Elex S.; Mcintire, Hannah J.; Mazur, Marina; Schulz-Hildebrandt, Hinnerk; Leung, Hui Min; Tearney, Guillermo J.; Krick, Stefanie; Rowe, Steven M.; Barnes, Jarrod W.
errShare
errSave
The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study
err2024-05-01
err7
PREAI
errDonaldson, Scott H.; Corcoran, Timothy E.; Pilewski, Joseph M.; Laube, Beth L.; Mogayzel, Peter; Ceppe, Agathe; Wu, Jihong; Zeman, Kirby; Rowe, Steven M.; Nichols, David P.; Gifford, Alex H.; Bennett, William D.; Mayer-Hamblett, Nicole
errShare
errSave
Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor
err2024-05-01
err1
PREAI
errDuong, Jennifer; Pope, Christopher E.; Hayden, Hillary S.; Miller, Carson; Salipante, Stephen J.; Rowe, Steven M.; Solomon, George M.; Nichols, David; Hoffman, Lucas R.; Narkewicz, Michael R.; Green, Nicole
errShare
errSave
Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
errHELIYON
IF3.6
err2024-04-01
err0
errOAAI
errVijaykumar, Kadambari; Leung, Hui Min; Barrios, Amilcar; Wade, Justin; Hathorne, Heather Y.; Nichols, David P.; Tearney, Guillermo J.; Rowe, Steven M.; Solomon, George M.
errShare
errSave
Pulmonary Fibrosis Stakeholder Summit A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report
err2024-02-15
err2
errOAAI
errMontesi, Sydney B.; Gomez, Christian R.; Beers, Michael; Brown, Robert; Chattopadhyay, Ishanu; Flaherty, Kevin R.; Garcia, Christine Kim; Gomperts, Brigitte; Hariri, Lida P.; Hogaboam, Cory M.; Jenkins, R. Gisli; Kaminski, Naftali; Kim, Grace Hyun J.; Konigshoff, Melanie; Kolb, Martin; Kotton, Darrell N.; Kropski, Jonathan A.; Lasky, Joseph; Magin, Chelsea M.; Maher, Toby M.; McCormick, Mark; Moore, Bethany B.; Nickerson-Nutter, Cheryl; Oldham, Justin; Podolanczuk, Anna J.; Raghu, Ganesh; Rosas, Ivan; Rowe, Steven M.; Schmidt, William T.; Schwartz, David; Shore, Jessica E.; Spino, Cathie; Craig, J. Matthew; Martinez, Fernando J.
errShare
errSave
Potential systemic effects of acquired CFTR dysfunction in COPD
err2024-01-01
err6
PREAI
errMiravitlles, Marc; Criner, Gerard J.; Mall, Marcus A.; Rowe, Steven M.; Vogelmeier, Claus F.; Hederer, Bettina; Schoenberger, Matthias; Altman, Pablo
errShare
errSave
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis
err2024-01-01
err7
PREAI
errDonaldson, Scott H.; Corcoran, Timothy E.; Pilewski, Joseph M.; Mogayzel, Peter; Laube, Beth L.; Boitet, Evan R.; Harris, Elex S.; Ceppe, Agathe; Edwards, Lloyd J.; Zeman, Kirby; Wu, Jihong; Esther, Charles R.; Nichols, David P.; Bennett, William D.; Rowe, Steven M.
errShare
errSave
Hypoxia-induced cystic fibrosis transmembrane conductance regulator dysfunction is a universal mechanism underlying reduced mucociliary transport in sinusitis
err2023-12-11
err2
PREAI
errCho, Do-Yeon; Zhang, Shaoyan; Norwood, T. Graham; Skinner, Daniel; Hollis, Tonja A.; Ehrhardt, Marie L.; Yang, Lydia C.; Lim, Dong-Jin; Grayson, Jessica W.; Lazrak, Ahmed; Matalon, Sadis; Rowe, Steven M.; Woodworth, Bradford A.
errShare
errSave
Glutathione and bicarbonate nanoparticles improve mucociliary transport in cystic fibrosis epithelia
err2023-11-17
err2
PREAI
errCho, Do Yeon; Rivers, Nicholas J.; Lim, Dong-Jin; Zhang, Shaoyan; Skinner, Daniel; Yang, Lydia; Menon, Adithya J.; Kelly, Olivia Jo; Jones, Martin P.; Bicknell, Brenton T.; Grayson, Jessica W.; Harris, Elex; Rowe, Steven M.; Woodworth, Bradford A.
errShare
errSave